content

Exelixis and Invenra expand partnership to develop cancer antibodies

Exelixis and Invenra have extended their discovery and licensing partnership to include 20 more oncology targets for multi-specific antibodies, antibody-drug conjugates, and the development...

IAG Cargo reaches 10 million vaccine milestone, as it supports Crown Agents and UNICEF complete key shipments for vaccine equity

IAG Cargo, the cargo division of International Airlines Group (IAG) has announced that it has now transported over 10 million COVID vaccines, supporting global...

Etihad Cargo’s tonnage up 20% on pre-COVID volumes

Etihad Cargo, the cargo and logistics arm of Abu Dhabiโ€™s Etihad Aviation Group, has reclaimed 90 per cent of its pre-COVID destinations and recorded...

Aptar Pharma Granted Exclusive License Option by Pharmaxis to Develop and Promote High Payload Dry Powder Inhaler

Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that they have entered into an agreement with...

Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the U.S. FDA has approved an update to the emergency...

Moderna Announces Supply Agreement with Canada for Expanded Supply of Moderna’s COVID-19 Vaccine in 2022, in 2023 and in 2024

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,ย  announced a revised supply agreement with the Government of Canada for up...

Sinopharm signs with Bangladesh to jointly produce COVID-19 vaccines

Chinese pharmaceutical giant Sinopharm has signed an agreement with Bangladesh over the co-production of COVID-19 inactivated vaccines.ย  Five million vaccines will be finished and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read